Developer of a biotechnology platform designed to develop anti-cancer drugs. The company's platform develops anti-cancer drugs based on antibodies, such as monoclonal antibodies and double antibodies,...

Healthcare
Seoul, South Korea
Founded 2018
9 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$16.5M
Last Round
N/A

Get the full picture

Create a free account to unlock Apitbio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required